The prevailing model of NKX3.1 expression in human prostate cancer suggests that while the protein may decrease in PIN lesions, it is much more commonly decreased in invasive adenocarcinomas, and nearly completely lost in most, if not all, metastatic prostate adenocarcinomas [52], [59], [74]. This evidence concerns the gene NKX3-1 and prostate carcinoma.